Viropharma, Inc. (VPHM) Tops Q4 EPS by 7c; Guides FY Sales In-Line

February 27, 2013 7:33 AM EST
Get Alerts VPHM Hot Sheet
Price: $49.96 --0%

Financial Fact:
Research and development: 18.09M

Today's EPS Names:
Trade VPHM Now!
Join SI Premium – FREE
Viropharma, Inc. (NASDAQ: VPHM) reported Q4 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $106.5 million versus the consensus estimate of $103.06 million.

Viropharma, Inc. sees FY2013 revenue of $450-475 million, versus the consensus of $460.07 million.

For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment